ENO3

From WikiMD's Food, Medicine & Wellness Encyclopedia

Enolase 3 (ENO3), also known as beta-enolase, is an enzyme that in humans is encoded by the ENO3 gene. It is one of the three isoenzymes of enolase, a key glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP). ENO3 is predominantly expressed in muscle tissue, including skeletal and cardiac muscle, playing a crucial role in muscle metabolism and energy production.

Function[edit | edit source]

Enolase 3 functions within the glycolytic pathway, a critical process for energy production, especially in cells with high energy demands such as muscle cells. By catalyzing the conversion of 2-phosphoglycerate to phosphoenolpyruvate, ENO3 facilitates the production of ATP, which is essential for muscle contraction and relaxation. This enzyme's activity is therefore vital for maintaining muscle function and overall energy homeostasis in the body.

Structure[edit | edit source]

The ENO3 enzyme is a dimer composed of two identical subunits. Each subunit binds one magnesium ion (Mg^2+), which is necessary for its catalytic activity. The structure of ENO3 shares similarities with other enolase isoenzymes, such as alpha-enolase (ENO1) and gamma-enolase (ENO2), but it possesses unique amino acid sequences that confer its tissue-specific expression and functionality.

Clinical Significance[edit | edit source]

Alterations in ENO3 expression or activity have been implicated in various muscle disorders. For instance, mutations in the ENO3 gene can lead to metabolic myopathies, conditions characterized by muscle weakness and fatigue. These disorders underscore the importance of ENO3 in muscle energy metabolism and its potential as a target for therapeutic interventions.

In addition to its role in muscle physiology, ENO3 has been studied in the context of cancer. Although its expression is primarily in muscle tissues, changes in ENO3 levels have been observed in certain types of cancer, suggesting a possible role in tumor metabolism and growth. However, the exact mechanisms and implications of ENO3 involvement in cancer remain an area of ongoing research.

Genetic[edit | edit source]

The ENO3 gene is located on chromosome 17 in humans. Genetic studies have identified various polymorphisms within the ENO3 gene that may influence the enzyme's expression and activity, potentially affecting an individual's susceptibility to muscle-related diseases and conditions.

See Also[edit | edit source]

References[edit | edit source]


External Links[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD